Ardelyx, Inc. (ARDX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1150519,
    "name": "Ardelyx, Inc.",
    "stock_name": "Ardelyx, Inc.",
    "full_name": "Ardelyx, Inc.",
    "name_url": "stocks-analysis/ardelyx-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "5.92",
    "chg": 0.38,
    "chgp": "6.86%",
    "dir": 1,
    "prev_price": "5.54",
    "mcapval": "1,588.08",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US0396971071",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "5.03 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ardelyx-inc-1150519-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ardelyx, Inc. Stock Soars 20.96%, Hits Intraday High of $6.73",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ardelyx-inc-stock-soars-2096-hits-intraday-high-of-673-3667392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArdelyxInc_priceRelatedfactors_3667392.png",
        "date": "2025-11-03 17:43:31",
        "description": "Ardelyx, Inc. has seen notable stock activity today, with a significant intraday high. The company has experienced a robust weekly increase, although its long-term performance lags behind the S&P 500. Financial metrics reveal ongoing losses, yet year-to-date performance indicates some resilience amid market challenges."
      },
      {
        "title": "Ardelyx, Inc. Stock Hits Day Low of $5.49 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ardelyx-inc-stock-hits-day-low-of-549-amid-price-pressure-3585893",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArdelyxInc_priceRelatedfactors_3585893.png",
        "date": "2025-10-01 16:16:53",
        "description": "Ardelyx, Inc. has faced significant challenges, with its stock declining 7.55% today and 11.27% over the past week. Financial metrics reveal a pre-tax loss of USD 19.08 million and negative EBITDA, indicating ongoing difficulties. Despite a strong three-year performance, the company has underperformed in the past year."
      },
      {
        "title": "Ardelyx, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ardelyx-inc-technical-trend-changes-from-bullish-to-mildly-bullish-amid-mixed-signals-3579737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ArdelyxInc_technicaldot_3579737.png",
        "date": "2025-09-29 15:50:56",
        "description": "Ardelyx, Inc., a small-cap pharmaceutical company, has experienced notable stock fluctuations, with a recent closing price of $5.54. The stock's performance has varied significantly over different periods, showing a year-to-date return of 9.27%, while underperforming over the past year compared to the S&P 500."
      },
      {
        "title": "Ardelyx, Inc. Hits Day Low of $5.49 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ardelyx-inc-hits-day-low-of-549-amid-price-pressure-3579098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ArdelyxInc_priceRelatedfactors_3579098.png",
        "date": "2025-09-29 14:12:04",
        "description": "Ardelyx, Inc. has faced notable challenges, with shares declining significantly today and over the past week. The company reported a pre-tax loss of USD 19.08 million, alongside a decrease in net profit. Despite a positive year-to-date performance, it has underperformed compared to the broader market."
      },
      {
        "title": "Is Ardelyx, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ardelyx-inc-technically-bullish-or-bearish-3547022",
        "imagepath": "",
        "date": "2025-09-20 19:45:10",
        "description": "As of 9 September 2025, the technical trend for Ardelyx, Inc. has changed from mildly bullish to bullish. The current stance is bullish, with key indicators supporting this position including a bullish MACD on the weekly timeframe, bullish moving averages on the daily timeframe, and a bullish OBV on both weekly and monthly timeframes. However, the weekly RSI is bearish, which indicates some short-term weakness. \n\nIn terms of performance, Ardelyx has shown a 10.50% return over the past month compared to the S&P 500's 2.33%, and a significant 390.08% return over the past three years against the S&P 500's 70.41%...."
      },
      {
        "title": "Is Ardelyx, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ardelyx-inc-overvalued-or-undervalued-3543470",
        "imagepath": "",
        "date": "2025-09-20 18:20:16",
        "description": "As of 6 November 2019, the valuation grade for Ardelyx, Inc. moved from does not qualify to risky, indicating a shift in perception regarding its financial health. Based on the available metrics, Ardelyx appears to be overvalued, particularly given its negative profitability indicators. The company has a Price to Book Value of 6.04, an EV to EBIT of -20.67, and an EV to EBITDA of -21.91, all of which suggest that the stock is trading at a premium despite its losses.\n\nIn comparison to peers, Ardelyx's valuation ratios are concerning; for instance, Ligand Pharmaceuticals, Inc. has a P/E of -67.27 and an EV to EBITDA of 132.07, while MannKind Corp. shows a P/E of 38.35 and an EV to EBITDA of 18.98, indicating that Ardelyx is not competitively positioned within its industry. Furthermore, while Ardelyx has shown a strong 3-year return of 390.08%, this is contrasted by a recent 1-week decline of -3.89% against th..."
      }
    ],
    "total": 11,
    "sid": "1150519",
    "stock_news_url": "https://www.marketsmojo.com/news/ardelyx-inc-1150519"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Ardelyx, Inc. Stock Soars 20.96%, Hits Intraday High of $6.73

2025-11-03 17:43:31

Ardelyx, Inc. has seen notable stock activity today, with a significant intraday high. The company has experienced a robust weekly increase, although its long-term performance lags behind the S&P 500. Financial metrics reveal ongoing losses, yet year-to-date performance indicates some resilience amid market challenges.

Ardelyx, Inc. Stock Hits Day Low of $5.49 Amid Price Pressure

2025-10-01 16:16:53

Ardelyx, Inc. has faced significant challenges, with its stock declining 7.55% today and 11.27% over the past week. Financial metrics reveal a pre-tax loss of USD 19.08 million and negative EBITDA, indicating ongoing difficulties. Despite a strong three-year performance, the company has underperformed in the past year.

Ardelyx, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-09-29 15:50:56

Ardelyx, Inc., a small-cap pharmaceutical company, has experienced notable stock fluctuations, with a recent closing price of $5.54. The stock's performance has varied significantly over different periods, showing a year-to-date return of 9.27%, while underperforming over the past year compared to the S&P 500.

Ardelyx, Inc. Hits Day Low of $5.49 Amid Price Pressure

2025-09-29 14:12:04

Ardelyx, Inc. has faced notable challenges, with shares declining significantly today and over the past week. The company reported a pre-tax loss of USD 19.08 million, alongside a decrease in net profit. Despite a positive year-to-date performance, it has underperformed compared to the broader market.

Is Ardelyx, Inc. technically bullish or bearish?

2025-09-20 19:45:10

As of 9 September 2025, the technical trend for Ardelyx, Inc. has changed from mildly bullish to bullish. The current stance is bullish, with key indicators supporting this position including a bullish MACD on the weekly timeframe, bullish moving averages on the daily timeframe, and a bullish OBV on both weekly and monthly timeframes. However, the weekly RSI is bearish, which indicates some short-term weakness. In terms of performance, Ardelyx has shown a 10.50% return over the past month compared to the S&P 500's 2.33%, and a significant 390.08% return over the past three years against the S&P 500's 70.41%....

Is Ardelyx, Inc. overvalued or undervalued?

2025-09-20 18:20:16

As of 6 November 2019, the valuation grade for Ardelyx, Inc. moved from does not qualify to risky, indicating a shift in perception regarding its financial health. Based on the available metrics, Ardelyx appears to be overvalued, particularly given its negative profitability indicators. The company has a Price to Book Value of 6.04, an EV to EBIT of -20.67, and an EV to EBITDA of -21.91, all of which suggest that the stock is trading at a premium despite its losses. In comparison to peers, Ardelyx's valuation ratios are concerning; for instance, Ligand Pharmaceuticals, Inc. has a P/E of -67.27 and an EV to EBITDA of 132.07, while MannKind Corp. shows a P/E of 38.35 and an EV to EBITDA of 18.98, indicating that Ardelyx is not competitively positioned within its industry. Furthermore, while Ardelyx has shown a strong 3-year return of 390.08%, this is contrasted by a recent 1-week decline of -3.89% against th...

View All News